According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -6,46ย โฌ. In 2024 the company made an earnings per share (EPS) of -7,57ย โฌ an increase over its 2023 EPS that were of -8,05ย โฌ.